Type E Botulinum Toxin Purification With Sequential Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying botulinum toxin yield low amounts of biologically active and stable botulinum toxin, typically less than about 10%, and there is a need for improved purification methods to achieve higher purity and activity.
Innovation Solution
A method involving cation exchange chromatography, hydrophobic interaction chromatography, and mixed mode chromatography, including trypsin activation, is used to purify type E botulinum toxin, utilizing specific resin types and buffers to achieve high purity and activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If precipitation and tangential flow filtration operations are used to purify botulinum toxin, then the toxin can be purified in complexed form, but the yield is low (typically less than 10%)
Solution Approach 1:
The purification process is divided into multiple sequential chromatography steps (CEX, HIC, mixed-mode) rather than using a single precipitation step. Each chromatography step targets specific impurities while preserving the toxin complex, achieving both high purity and high yield through progressive separation.
Solution Approach 2:
The invention optimizes multiple parameters including pH gradients, salt concentrations, and buffer compositions across different chromatography steps. These parameter changes enable selective binding and elution of the botulinum toxin complex while excluding impurities, resolving the contradiction between purity and yield.
2Manufacturing precision
If size exclusion, ion exchange, and/or affinity chromatography are used to purify botulinum toxin, then purification can be achieved, but the yield and activity of biologically active toxin remain insufficient
Solution Approach 1:
The invention employs a composite purification strategy combining three different chromatography modalities (CEX, HIC, mixed-mode) rather than relying on a single method. This composite approach leverages the strengths of each technique to achieve both high purity and preservation of biological activity, as each step targets different impurity types while maintaining toxin integrity.
Solution Approach 2:
The CEX chromatography step is performed first to remove bulk impurities and prepare the sample for subsequent HIC and mixed-mode steps. This preliminary action prevents overload of later columns and ensures that the toxin remains in its active complexed form throughout the purification sequence.
3Productivity
If recombinant means are used to synthesize heavy or light chains individually, then production can be achieved, but complete and biologically active botulinum toxin protein cannot be obtained
Solution Approach 1:
Instead of synthesizing chains separately and attempting to reassemble them, the invention extracts and purifies the complete, naturally assembled botulinum toxin complex directly from bacterial culture. This extraction approach preserves the native quaternary structure and biological activity that would be difficult to achieve through recombinant reassembly.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves botulinum toxin purity of 99% or more, maintaining activity, and the toxin remains effective for up to a month post-injection, suitable for biopharmaceuticals and cosmetic applications.
Implementation Method 1
purifying the pre-treated culture fluid using cation exchange chromatography
Implementation Method 2
purifying an eluate purified in operation (b) using hydrophobic interaction chromatography
Implementation Method 3
purifying a trypsin reaction solution using mixed mode chromatography
Implementation Method 4
activating the botulinum toxin by reacting it with trypsin
Data Source
AI summary
The present invention relates to a method for purifying botulinum toxin (BTX). More specifically, the method is performed in the order of purification steps using cation exchange chromatography (CEX), hydrophobic interaction chromatography (HIC), and mixed mode chromatography (cation exchange (phosphate) and affinity (calcium)), the method further comprising the step of treating trypsin to activate the botulinum toxin. Therefore, the method can purify botulinum toxin having excellent purity and activity and thus can be useful in producing botulinum toxin.